
- Volume 0 0
Generic Times Product News
AmlodipineBesylate Tablets
Marketed by:Teva PharmaceuticalsUSA (North Wales, Pa)
Compared to:Norvasc Tablets(Pfizer Inc)
Indication:July 10, 2007?Teva Pharmaceuticals announcedthe introduction and availability of AmlodipineBesylate Tablets. These tablets are indicated for thetreatment of hypertension (used alone or in combinationwith other antihypertensive agents); chronicstable angina (used alone or in combination withother antianginal drugs); and confirmed or suspectedvasospastic angina (Prinzmetal?s or variant angina;used as monotherapy or in combination withother antianginal drugs). These tablets are availablein 2.5-, 5-, and 10-mg strengths in bottles of 90tablets and in 5-mg strength in bottles of 300tablets.
Dosage Form:Tablets: 2.5, 5, and 10 mg
For More Information:
Atenolol Tablets USP
Marketed by:Caraco PharmaceuticalLaboratories Ltd (Detroit, Mich)
Compared to:Tenormin (AstraZenecaPharmaceuticals LP)
Indication:July 11, 2007?CaracoPharmaceutical Laboratoriesannounced that the FDA grantedfinal approval for its abbreviated new drug applicationfor Atenolol Tablets USP. Atenolol Tablets areindicated in the management of hypertension, thelong-term management of patients with anginapectoris, and the management of hemodynamicallystable patients with definite or suspected acutemyocardial infarction to reduce cardiovascular mortality.These tablets are available in 3 strengths: 25,50, and 100 mg.
Dosage Form:Tablets: 25, 50, and 100 mg
For More Information:
Loratadine OrallyDisintegratingTablets
Marketed by:Ohm Laboratories Inc(Princeton, NJ), a whollyowned subsidiary ofRanbaxy LaboratoriesLtd (RLL)
Compared to:Claritin Reditabs (Schering-Plough HealthcareProducts)
Indication:April 12, 2007?Ohm Laboratories announced thatRLL received FDA approval to manufacture andmarket its Loratadine Orally Disintegrating Tablets,10 mg. This long-acting antihistamine agent is indicatedfor the temporary relief of runny nose; sneezing;itching of the nose or throat; and itchy, wateryeyes due to hay fever or other respiratory allergiesin adults and children aged 6 years and older.
Dosage Form:Tablets: 10 mg
For More Information:
Metoprolol SuccinateExtended-release Tablets
Marketed by:KV Pharmaceutical Co(St. Louis, Mo)
Compared to:Toprol-XL (AstraZenecaPharmaceuticals LP)
Indication:July 26, 2007?KV PharmaceuticalCo announced the launch of its100- and 200-mg strengths of metoprolol succinateextended-release tablets. These tablets are indicatedfor the treatment of hypertension (used alone orin combination with other antihypertensive agents);the long-term management of angina pectoris; andthe treatment of stable, symptomatic (NYHA Class IIor III) heart failure of ischemic, hypertensive, or cardiomyopathicorigin.
Dosage Form:Tablets: 100 and 200 mg
For More Information:
Articles in this issue
about 18 years ago
Calming the Symptoms of Menopauseabout 18 years ago
Zoster Vaccineabout 18 years ago
pharmacy TECHNOLOGY productsabout 18 years ago
health-systems PRODUCT newsabout 18 years ago
can you READ these Rxs?about 18 years ago
can you READ these Rxs?about 18 years ago
compounding HOTLINEabout 18 years ago
Human HRT Leads Compounding Renaissanceabout 18 years ago
Prescription-overdose Deaths Surpass Car-accident Deathsabout 18 years ago
43 Years Later, a DES Case Is Still in the Court SystemNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.